1887

Journal of General Virology header logo

Volume 71, Issue 4

Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice Free

Abstract

Mouse L cell lines constitutively expressing glycoproteins B or D of herpes simplex virus type 1 (LTKgB and LTKgD respectively) were used to study the longevity of the immune response to these viral glycoproteins in mice. Two immunizations with the cell lines were necessary to induce a persisting antibody response (present for over 200 days). Only LTKgD induced a neutralizing antibody response in mice and this also remained at high titres over 200 days after two inoculations. The presence in mice of precursor cytotoxic T lymphocytes specific for gB expressed in the L cells was also shown up to 270 days after immunization. Mice immunized with the cell lines showed an increased rate of virus clearance from the ear pinna, inoculation with LTKgD resulting in more clearance than LTKgB at 7 days post-immunization. This type of protection was reduced with time after inoculation, until by day 161 there was no significant difference in virus titres between immunized and control groups. However, LTKgD immunization protected against the establishment of latent infections in the ganglia of mice even up to 186 days postinoculation.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1990
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-4-863
1990-04-01
2024-10-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/4/JV0710040863.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-4-863&mimeType=html&fmt=ahah

References

  1. Ashley R., Mertz G. J., Corey L. 1987; Detection of asymptomatic herpes simplex virus infections after vaccination. Journal of Virology 61:264–268
     [Google Scholar]
  2. Berman P. W., Gregory T., Crase D., Laskey L. A. 1985; Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 227:1490–1492
     [Google Scholar]
  3. Blacklaws B. A., Nash A. A., Darby G. 1987; Specificity of the immune response of mice to herpes simplex virus glycoproteins gB and gD constitutively expressed in L cell lines. Journal of General Virology 68:1103–1114
     [Google Scholar]
  4. Cantin E. M., Eberle R., Baldick J. L., Moss B., Willey D. E., Notkins A. L., Openshaw H. 1987; Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proceedings of the National Academy of Sciences, U.S.A 84:5908–5912
     [Google Scholar]
  5. Cappel R., Sprecher S., Rickaert F., De Cuyper F. 1982; Immune response to a DNA-free herpes simplex vaccine in man. Archives of Virology 73:61–67
     [Google Scholar]
  6. Carter V. C., Schaffner P. A., Tevethia S. S. 1981; The involvement of herpes simplex virus type 1 glycoproteins in cell- mediated immunity. Journal of Immunology 126:1655–1660
     [Google Scholar]
  7. Chan W. L., Lukig M. L., Liew F. Y. 1985; Helper T cells induced by an immunopurified herpes simplex virus type 1 (HSV-1) 115 kilodalton glycoprotein (gB) protect mice against HSV-1 infection. Journal of Experimental Medicine 162:1304–1318
     [Google Scholar]
  8. Colombatti A., Hilgers J. 1979; A radioimmunoassay for virus antibody using binding of 125I-labelled protein A. Journal of General Virology 43:395–401
     [Google Scholar]
  9. Cremer K. J., Mackett M., Wohlenberg C., Notkins A. L., Moss B. 1985; Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228:737–740
     [Google Scholar]
  10. Eisenberg R. J., Cerini C. P., Heilman C. J., Joseph A. D., Dietzschold B., Golub E., Long D., Ponce de Leon M., Cohen G. H. 1985; Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. Journal of Virology 56:1014–1017
     [Google Scholar]
  11. Hill T. J., Field H. J., Blyth W. A. 1975; Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Journal of General Virology 28:341–353
     [Google Scholar]
  12. Jennings S. R., Rice P. L., Pan S., Knowles B. B., Tevethia S. S. 1984; Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes. Journal of Immunology 132:475–481
     [Google Scholar]
  13. Kapoor A. K., Buckmaster A., Nash A. A., Field H. J., Wildy P. 1982; Role of neutralising antibodies and T-cells in pathogenesis of herpes simplex virus infection in congenitally athymic mice. Immunology Letters 5:259–265
     [Google Scholar]
  14. Krishna S., Blacklaws B. A., Overton H. A., Bishop D. H. L., Nash A. A. 1989; Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts. Journal of General Virology 70:1805–1814
     [Google Scholar]
  15. Koga J., Chatterjee S., Whitley R. J. 1986; Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Virology 151:385–389
     [Google Scholar]
  16. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
     [Google Scholar]
  17. Lawman M. J. P., Courtney R. J., Eberle R., Schaffer P. A., O’Hara M. K., Rouse B. T. 1980; Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infection and Immunity 30:451–461
     [Google Scholar]
  18. Long D., Madara T. J., Ponce de Leon M., Cohen G. H., Montgomery P. C., Eisenberg R. J. 1984; Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infection and Immunity 43:761–764
     [Google Scholar]
  19. Mcgeoch D. J., Dolan A., Donald S., Rixon F. J. 1985; Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. Journal of Molecular Biology 181:1–13
     [Google Scholar]
  20. Mcgeoch D. J., Dalrymple M. A., Davison A. J., Dolan A., Frame M. C., Mcnab D., Perry L. J., Scott J. E., Taylor P. 1988; The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. Journal of General Virology 69:1531–1574
     [Google Scholar]
  21. Mclaughlin-Taylor E., Willey D. E., Cantin E. M., Eberle R., Moss B., Openshaw H. 1988; A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice. Journal of General Virology 69:1731–1734
     [Google Scholar]
  22. Marlin S. D., Highlander S. L., Holland T. C., Levine M., Glorioso J. C. 1986; Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature- dependent alterations in gB processing and virus production. Journal of Virology 59:142–153
     [Google Scholar]
  23. Martin S., Rouse B. T. 1987; The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection. Journal of Immunology 138:3431–3437
     [Google Scholar]
  24. Martin S., Moss B., Berman P. W., Laskey L. A., Rouse B. T. 1987; Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. Journal of Virology 61:726–734
     [Google Scholar]
  25. Martin S., Courtney R. J., Fowler G., Rouse B. T. 1988; Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins. Journal of Virology 62:2265–2273
     [Google Scholar]
  26. Mertz G. J., Peterman G., Ashley R., Jourden J. L., Salter D., Morrison L., Mclean A., Corey L. 1984; Herpes simplex virus type-2 glycoprotein-subunit vaccine: tolerance and humoral and cellular responses in humans. Journal of Infectious Diseases 150:242–249
     [Google Scholar]
  27. Minson A. C., Wildy P., Buchan A., Darby G. 1978; Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA. Cell 13:581–587
     [Google Scholar]
  28. Nash A. A., Field H. J., Quartey-Papafio R. 1980; Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. Journal of General Virology 48:351–357
     [Google Scholar]
  29. Nash A. A., Leung K.-N., Wildy P. 1985; The T-cell-mediated immune response of mice to herpes simplex virus. In The Herpesviruses 4 pp. 87–102 Roizman B., Lopez C. Edited by New York: Plenum Press;
     [Google Scholar]
  30. Nash A. A., Jayasuriya A., Phelan J., Cobbold S. P., Waldmann H., Prospero T. 1987; Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68:825–833
     [Google Scholar]
  31. Norrild B. 1985; Humoral response to herpes simplex virus infections. In The Herpesviruses 4 pp. 69–86 Roizman B., Lopez C. Edited by New York: Plenum Press;
     [Google Scholar]
  32. Pachl C., Burke R. L., Stuve L. L., Sanchez-Pescador L., Van Nest G., Masiarz F., Dina D. 1987; Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells. Journal of Virology 61:315–325
     [Google Scholar]
  33. Paoletti E., Lipinskas B. R., Samsonoff C., Mercer S., Panicali D. 1984; Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proceedings of the National Academy of Sciences, U.S.A 81:193–197
     [Google Scholar]
  34. Pfizenmaier K., Jung H., Starzinski-Powitz A., Rollinghoff M., Wagner H. 1977; The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. Journal of Immunology 119:939–944
     [Google Scholar]
  35. Richman D. D., Buckmaster A., Bell S., Hodgman C., Minson A. C. 1986; Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. Journal of Virology 57:647–655
     [Google Scholar]
  36. Roberts P. L., Duncan B. E., Raybould T. J. G., Watson D. H. 1985; Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge. Journal of General Virology 66:1073–1085
     [Google Scholar]
  37. Rosenthal K. L., Smiley J. R., South S., Johnson D. C. 1987; Cells expressing herpes simplex virus glycoprotein gC but not gB, gD or gE are recognized by murine virus-specific cytotoxic T lympho-cytes. Journal of Virology 61:2438–2447
     [Google Scholar]
  38. Sanchez-Pescador L., Burke R. L., Ott G., Nest G. V. 1988; The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine. Journal of Immunology 141:1720–1727
     [Google Scholar]
  39. Schrier R. D., Pizer L. I., Moorhead J. W. 1983; Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. Journal of Immunology 130:1413–1418
     [Google Scholar]
  40. Scriba M. 1977; Extraneural localization of herpes simplex virus in latently infected guinea pigs. Nature; London: 267529–531
     [Google Scholar]
  41. Simmons A., Nash A. A. 1984; Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. Journal of Virology 52:816–821
     [Google Scholar]
  42. Simmons A., Nash A. A. 1985; Role of antibody in primary and recurrent herpes simplex virus infection. Journal of Virology 53:944–948
     [Google Scholar]
  43. Spear P. G. 1985; Glycoproteins specified by herpes simplex virus. In The Herpesviruses 3 pp. 315–356 Roizman B. Edited by New York: Plenum Press;
     [Google Scholar]
  44. Stanberry L. R., Bernstein D. I., Burke R. L., Pachl C. 1987; Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. Journal of Infectious Diseases 155:914–920
     [Google Scholar]
  45. Zarling J. M., Moran P. A., Burke R. L., Pachl C., Berman P. W., Laskey L. A. 1986; Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. Journal of Immunology 136:4669–4673
     [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-71-4-863
Loading
Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice
J. Gen. Virol. 71, 863 (1990); https://doi.org/10.1099/0022-1317-71-4-863
/content/journal/jgv/10.1099/0022-1317-71-4-863
/content/journal/jgv/10.1099/0022-1317-71-4-863
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error